Kintara Therapeutics Inc

NASDAQ:KTRA

0.15

-0.01 (-5.82%)

7:59:28 PM EDT: $0.14 -0.01 (-4.23%)

Market Cap (Intraday)	8.23M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$6.08 Million
Adjusted EPS	-$0.25

See more estimates

10-Day MA	$0.13
50-Day MA	$0.11
200-Day MA	$1.68

See more pivots

Kintara Therapeutics Inc Stock, NASDAQ:KTRA

9920 Pacific Heights Boulevard, Suite 150, San Diego, California 92121

United States of America

Phone: +1.858.350.4364

Number of Employees: 17

http://www.kintara.com

Description

Kintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. Its product pipeline includes VAL-083 and REM-001. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA.